As the United States makes efforts to eradicate Covid-19 under a new president’s administration, the Food and Drug Administration is tasked with rebuilding the regulatory agency's...
Technically, the Dow and S&P 500 snapped their 7-day winning streak. Q4 2020 hedge fund letters, conferences and more Technically. A Down Day For The Dow...
The U.S. Food and Drug Administration granted Emergency Use Authorization (EUA) to a combination of Eli Lilly and AbCellera’s monoclonal antibody bamlanivimab and the Lilly antibody etesevimab...
The FDA has granted an emergency license for Eli Lilly’s COVID-19 antibody combination therapy, to reduce chances of severe COVID-19
CNBC Transcript: Johnson & Johnson Chairman & CEO Alex Gorsky speaks with Meg Tirrell live during CNBC’s Healthy Returns Spotlight today on the company’s one-shot coronavirus...
CNBC transcript: Walgreens Pharmacy & Healthcare SVP Rick Gates speaks with Meg Tirrell live during CNBC’s Healthy Returns Spotlight today on getting a COVID vaccine appointment...
Covid-19’s impact has been felt across most industries. H.C. Wainwright analyst Ram Selvaraju cites the pandemic as the reason behind lowered sales projections for Rockwell Medical...
Credit: ETH Zurich /Giulia Marthaler Scientific and public health experts have been raising the alarm for decades, imploring public officials to prepare for the inevitability of...
LAMP and antigen COVID-19 tests promise inexpensive, accurate, and fast results to help manage the pandemic.
The United States is spiraling. Seven-day averages for positive COVID-19 cases have exceeded 250,000 per day, having risen sharply after the Thanksgiving holiday and rising again...
Heat Biologics shares spiked 77% as the biopharma company reported positive interim data from the Phase 2 trial of its lung cancer treatment. The Phase 2...
Novavax (NVAX) was the coronavirus stock to hold last year, as the company punched far above its weight and delivered investors incredible returns.
The U.S. Food and Drug Administration approved Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel; liso-cel) for adults with relapsed or refractory large B-Cell lymphoma after two or more...
South Africa delayed the distribution of the AstraZeneca-University of Oxford Covid-19 vaccine after data suggested it “provides minimal protection” against mild disease from the South African...
Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from...
The Astrazeneca/Oxford vaccine offers only limited protection against mild disease caused by the South African variant of the coronavirus
Amazon and its subsidiary Whole Foods have been cleared of wrongdoing by a US federal judge for allegedly illegally punishing employees who chose to show support...
Bristol Myers Squibb announced on Feb. 5 that the US Food and Drug Administration (FDA) has approved its lymphoma drug, Breyanzi, a CAR-T (chimeric antigen receptor...
Johnson & Johnson has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) of its investigational single-dose COVID-19 vaccine...
Johnson & Johnson’s Janssen Biotech submitted an application to the U.S. Food and Drug Administration for emergency use authorization (EUA) for a single-dose Covid-19 vaccine.
Less than one week after posting a positive first-look at Phase III vaccine data, Maryland-based Novavax began the rolling review process for authorization of NVX-CoV2373 in...
AstraZeneca reported that the company's Phase III KESTREL trial of Imfinzi (durvalumab) failed to meet the primary endpoint of improving overall survival compared to the EXTREME treatment...
Ocugen (OCGN) announced it had finalized its deal with India-based Bharat Biotech top commercialize COVAXIN COVID-19 vaccine already in use in India
J&J said its EUA will be based on topline efficacy and safety data from the nearly 44,000-patient Phase III ENSEMBLE trial
Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for The post J&J asks FDA for emergency clearance...
Gilead’s COVID-19 drug Veklury (remdesivir) is helping the company through disruption caused by the pandemic and patent expiry The post Veklury rescues Gilead from COVID doldrums...
Today we will know the important employment data of the United States, with the publication of the NFP and the unemployment rate from last month
Futures Hit All Time High, Oil Soars Ahead Of Jobs Report With overnight US equity futures rising for a 5th straight day, tracking global markets, the...
NAIOP conducted its seventh survey of its U.S. members on the impacts of COVID-19. Since April, the association has examined the pandemic’s effects on commercial real...
Speaking with GEN last month, a Jazz executive said the company is moving toward expanding in neuroscience beyond sleep indications, through a mix of multiple indications...